Andé, France

Jerôme Emile Georges Guillemont

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 101(Granted Patents)


Location History:

  • Andé, FR (2008 - 2018)
  • Ande, FR (2016 - 2020)

Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Jerôme Emile Georges Guillemont - Innovator in Antibacterial Compounds

Introduction

Jerôme Emile Georges Guillemont, based in Andé, France, is an accomplished inventor known for his significant contributions to the field of antibacterial compounds. With a remarkable portfolio of 27 patents, Guillemont has been at the forefront of innovative solutions aimed at combating bacterial infections.

Latest Patents

Among his latest patents, Guillemont has developed novel compounds known as antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones. These inventions relate to compounds that inhibit the activity of the FabI enzyme, which play a crucial role in the treatment of bacterial infections. In addition to the compounds themselves, the patents cover pharmaceutical compositions that incorporate these novel compounds, as well as the chemical processes used to prepare them.

Career Highlights

Throughout his career, Jerôme Guillemont has made substantial contributions while working at notable institutions, including Janssen Sciences Ireland UC and Janssen R&D Ireland. His work at these companies has solidified his reputation as an expert in pharmaceutical development, focusing on breakthroughs in antibacterial therapies.

Collaborations

Guillemont has worked alongside esteemed colleagues, including David Francis Alain Lançois and Magali Madeleine Simone Motte. These collaborations have facilitated innovative research and development efforts, further enhancing the potential applications of his inventions in the pharmaceutical industry.

Conclusion

With his extensive experience and a proven track record of innovation, Jerôme Emile Georges Guillemont continues to be a pivotal figure in the development of antibacterial treatments. His dedication to advancing medical science through inventions and patents demonstrates his commitment to improving public health through effective and innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…